Medeon Biodesign Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Medeon Biodesign's earnings have been declining at an average annual rate of -32.4%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been declining at an average rate of 13.6% per year.
Wichtige Informationen
-32.4%
Wachstumsrate der Gewinne
-32.0%
EPS-Wachstumsrate
Medical Equipment Wachstum der Industrie | 11.5% |
Wachstumsrate der Einnahmen | -13.6% |
Eigenkapitalrendite | -44.6% |
Netto-Marge | -382.6% |
Nächste Ertragsaktualisierung | 11 Nov 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Aufschlüsselung der Einnahmen und Ausgaben
Wie Medeon Biodesign Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Jun 24 | 212 | -811 | 186 | 715 |
31 Mar 24 | 200 | -1,231 | 178 | 698 |
31 Dec 23 | 196 | -1,205 | 186 | 667 |
30 Sep 23 | 178 | -1,185 | 199 | 631 |
30 Jun 23 | 173 | -1,115 | 185 | 612 |
31 Mar 23 | 151 | -675 | 179 | 567 |
31 Dec 22 | 298 | -434 | 153 | 522 |
30 Sep 22 | 271 | -356 | 125 | 500 |
30 Jun 22 | 240 | -410 | 115 | 460 |
31 Mar 22 | 249 | -357 | 109 | 441 |
31 Dec 21 | 69 | -540 | 108 | 416 |
30 Sep 21 | 142 | -488 | 105 | 372 |
30 Jun 21 | 141 | -426 | 102 | 336 |
31 Mar 21 | 117 | -389 | 97 | 306 |
31 Dec 20 | 123 | -371 | 98 | 290 |
30 Sep 20 | 162 | -399 | 114 | 294 |
30 Jun 20 | 279 | -351 | 132 | 300 |
31 Mar 20 | 377 | -306 | 140 | 307 |
31 Dec 19 | 454 | -262 | 143 | 301 |
30 Sep 19 | 412 | -221 | 130 | 272 |
30 Jun 19 | 350 | -200 | 112 | 240 |
31 Mar 19 | 300 | -169 | 106 | 201 |
31 Dec 18 | 674 | 257 | 107 | 197 |
30 Sep 18 | 639 | 222 | 108 | 216 |
30 Jun 18 | 604 | 215 | 109 | 214 |
31 Mar 18 | 596 | 181 | 109 | 229 |
31 Dec 17 | 165 | -248 | 103 | 216 |
30 Sep 17 | 148 | -240 | 97 | 206 |
30 Jun 17 | 120 | -240 | 89 | 199 |
31 Mar 17 | 66 | -225 | 78 | 178 |
31 Dec 16 | 29 | -219 | 71 | 163 |
30 Sep 16 | 0 | -204 | 63 | 154 |
30 Jun 16 | 0 | -184 | 58 | 150 |
31 Mar 16 | 0 | -173 | 53 | 149 |
31 Dec 15 | 0 | -148 | 47 | 135 |
30 Sep 15 | 0 | -116 | 38 | 110 |
30 Jun 15 | 0 | -105 | 32 | 96 |
31 Mar 15 | 0 | -84 | 28 | 75 |
31 Dec 14 | 0 | -73 | 24 | 65 |
30 Sep 14 | 0 | -57 | 24 | 51 |
30 Jun 14 | 0 | -41 | 25 | 37 |
31 Mar 14 | 0 | -37 | 23 | 31 |
Qualität der Erträge: 6499 is currently unprofitable.
Wachsende Gewinnspanne: 6499 is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 6499 is unprofitable, and losses have increased over the past 5 years at a rate of 32.4% per year.
Beschleunigtes Wachstum: Unable to compare 6499's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: 6499 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.5%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 6499 has a negative Return on Equity (-44.6%), as it is currently unprofitable.